Table 2.
10-year modelled cardiovascular disease risk (UK Prospective Diabetes Risk Engine version 3β) in the ADDITION-Europe trial cohort at baseline and 5.7 years by centre and combined
| Routine care | Intensive treatment | |||||||
|---|---|---|---|---|---|---|---|---|
| Centre | Total with data* (% of randomized) | Mean at baseline (sd) | Mean at follow-up (sd) | Mean change baseline to follow-up (sd) | Total with data* (% of randomized) | Mean at baseline (sd) | Mean at follow-up (sd) | Mean change baseline to follow-up (sd) |
| Cambridge | 285 (75%) | 27.7 (13.8) | 22.8 (14.1) | –5.1 (14.4) | 334 (77%) | 29.3 (15.1) | 22.1 (14.4) | –6.4 (14.0) |
| Leicester | 77 (81%) | 23.9 (11.4) | 19.9 (13.9) | –2.3 (9.5) | 56 (93%) | 27.5 (13.9) | 19.0 (12.0) | –8.5 (11.2) |
| Denmark | 423 (73%) | 25.4 (12.2) | 21.5 (13.7) | –3.7 (12.8) | 594 (71%) | 25.0 (13.2) | 20.2 (13.7) | –4.7 (12.1) |
| The Netherlands | 152 (66%) | 33.6 (14.3) | 23.3 (14.7) | –9.8 (16.3) | 180 (73%) | 35.8 (15.7) | 20.7 (13.8) | –14.7 (11.4) |
| Combined | 937 (73%) | 27.4 (13.3) | 22.1 (14.0) | –5.0 (12.2) | 1164 (74%) | 28.1 (14.7) | 20.7 (13.8) | –6.9 (9.0) |
*
Total with risk score available at baseline and follow-up.